秋尽冬始，由广东省医师协会消化内镜学医师分会主办，我院小肠内镜科、小肠疾病中心承办的第二届小肠疾病论坛于11月10日在广州召开。大会主席由我院消化内科胡品津教授、院长吴小剑教授、广东省医师协会消化内镜学医师分会主任委员沙卫红教授共同担任，我院小肠内镜 ...

It is driven by rising diabetes rates. The global gastroparesis drugs market is set to grow by $1.42b from 2024 to 2028, with ...

Approximately 25% to 30% of cases of gastroparesis are not idiopathic and are not secondary to diabetes or postoperative gastric motor dysfunction. Etiologies in such instances include disorders ...

During the study period, 15 patients referred for persistent unexplained vomiting were evaluated for suspected post-infectious gastroparesis. Three patients with normal gastric emptying studies ...

Report on how AI is redefining market landscape - The global gastroparesis drugs market size is estimated to grow by USD 1.42 ...

While you may have never heard of it, gastroparesis is a chronic condition that affects the way food passes through the ...

“My family thought I was getting ready to die.” Around the same time she stopped taking Ozempic, Barber was diagnosed with gastroparesis: a condition also known as stomach paralysis that ...

Analysis of real-world data compared patients on GIMOTI (n=51) to Oral Metoclopramide (n=41), both taking GLP-1s, showing ...

“I have a lot of pain in my stomach," she said. "I have a lot of pain in my chest. I feel lots of nausea." Smoot suffers from ...

The following is a summary of “Brain Fog in Gastrointestinal Disorders: Small Intestinal Bacterial Overgrowth, Gastroparesis, ...

Evoke Pharma Inc (NASDAQ:EVOK) shares are trading higher Monday after the company presented GLP-1 data for users with ...

Evoke Pharma Inc. (EVOK) and Eversana Life Science Services, LLC. announced statistically significant comparative data on its study ...